Despite completing DRAP registration and obtaining Cabinet Committee approval, vital cancer and specialty medicines remain legally unavailable across the country

Federal Minister for Commerce Jam Kamal Khan chaired a high-level review, directing Foreign Trade Wings to formulate country-specific plans prioritizing

Pakistan is moving toward WHO Maturity Level-3 accreditation by April 2027—a landmark step announced by Health Minister Syed Mustafa Kamal.

The Cabinet Committee for Drug Pricing, chaired by Finance Minister Muhammad Aurangzeb, has approved Maximum Retail Prices (MRPs) for 52

PPMA presented the pharmaceutical industry’s perspective on key sector issues, including the deregulation of non-essential medicines. The meeting was presided

DRAP has officially issued draft amendments regarding the Drugs Labelling and Packing Rules and is requesting feedback from stakeholders. We

The Pak-China Business Conference concluded with $1.4 Billion in total investment commitments, including 42 final-day deals! 🚀 This historic partnership

Tomorrow in Islamabad, the Pakistan–China B2B Investment Conference kicks off, bringing together over 450+ firms to forge the Sino-Pak Pharma

A new era of healthcare transparency begins. The Drug Regulatory Authority of Pakistan (DRAP) has established critical regulatory timelines to

Under the newly announced Federal Budget 2026-27, the government has officially exempted customs duties on critical cancer-related Active Pharmaceutical Ingredients

We are thrilled to announce a major milestone for the pharmaceutical industry! The Embassy of Pakistan in Beijing and CODA

A massive milestone for international trade and the pharmaceutical sector! Pakistan and Egypt are officially locking in fast-track pharmaceutical certifications